Vanguard Capital Management
ROIV icon

Vanguard Capital Management’s Roivant Sciences ROIV Stock Holding History

Vanguard Capital Management’s Portfolio ROIV Stock Details ROIV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$846M Buy
23,127,563
+1,004,365
+5% +$36.4M 0.02% 527
2026
Q2 		$783M Buy
22,123,198
+1,442,626
+7% +$42.6M 0.02% 558
2026
Q1 		$573M Buy
+20,680,572
New +$531M 0.01% 620

Other funds holding ROIV

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return
BlackRock
BlackRock New York $6.79T AUM 37.06% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.96T AUM 27.49% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.21T AUM
UBS Group
UBS Group Zurich, Switzerland $765B AUM 28.39% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.27T AUM 50.62% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.84T AUM 33.86% 1-Year Est. Return
Patient Square Capital
Patient Square Capital Menlo Park, California $627M AUM 115.4% 1-Year Est. Return

Vanguard Capital Management's ROIV Position: Q3 2026 in Review

Vanguard Capital Management increased its Roivant Sciences (ROIV) stake by 4.5% in Q3 2026, buying an estimated $36.4M and bringing the position to 23,127,563 shares worth $846M. The position accounts for 0.02% of the portfolio, ranked #527.

Vanguard Capital Management first reported a position in ROIV in Q1 2026 and has held it in 3 quarters since. 395 funds tracked by Wall St. Rank hold ROIV as of Q3 2026.

  • Vanguard Capital Management held 23,127,563 shares of Roivant Sciences worth $846M as of Q3 2026.
  • Vanguard Capital Management bought 1,004,365 Roivant Sciences shares in Q3 2026, an estimated $36.4M.
  • Roivant Sciences made up 0.02% of Vanguard Capital Management's portfolio in Q3 2026, its #527 holding.
  • Vanguard Capital Management first reported a position in Roivant Sciences in Q1 2026 and has held it in 3 quarters since.
  • 395 funds tracked by Wall St. Rank held Roivant Sciences as of Q3 2026.

Based on Vanguard Capital Management's 13F filing for Q3 2026, filed 13 Nov 2026.